Page last updated: 2024-09-03

arginine-glycine-aspartate-o-methyltyrosine amide and Disease Models, Animal

arginine-glycine-aspartate-o-methyltyrosine amide has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aragon-Sanabria, V; Bradbury, MS; Brennan, CW; Carlin, S; Chen, F; Chen, PM; Gonen, M; Huse, J; Juthani, R; Longo, VA; Ma, K; Madajewski, B; Overholtzer, M; Rudin, CM; Turker, MZ; Wiesner, U; Yoo, B; Zanzonico, P; Zhang, L1

Other Studies

1 other study(ies) available for arginine-glycine-aspartate-o-methyltyrosine amide and Disease Models, Animal

ArticleYear
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 01-01, Volume: 26, Issue:1

    Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Dasatinib; Disease Models, Animal; Drug Delivery Systems; Glioblastoma; Iodine Radioisotopes; Mice; Nanoparticles; Neoplasm Grading; Oligopeptides; Positron-Emission Tomography; Protein Kinase Inhibitors; Radioisotopes; Silicon Dioxide; Zirconium

2020